GLSGlenmark Life SciencesGLS info
$12.47info-0.24%24h
Global rank6154
Market cap$1.53B
Change 7d6.67%
YTD Performance58.63%
SP500 benchmarkOutperform
P/E0.33
P/S6.25
Revenue$244.33M
Earnings$55.71M
Dividend yield-
Main Sector
Healthcare

Glenmark Life Sciences GLS Total Debt

GLS Total Debt in 2022: $2.04M

According to Glenmark Life Sciences latest financial reports the total debt is $2.04M, an increase of 1319.60% to 2022. At the end of 2022 company had $143.65K total debt. This figure represents the debts and financial obligations that Glenmark Life Sciences combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.

Glenmark Life Sciences GLS Total Debt History from 2023 to 2022

-
Value:-

GLS Total Debt by year

YearTotal debtChange
2023$2.04M1319.60%
2022$143.65KInfinity%
2021$0-

View the Top Total Debt Stocks arrow right

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org